InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Contamine Jérôme. Director active across 1 company, notably LAKEFRONT BIOTHERAPEUTICS. Aggregated, 1 disclosures have been published. History available since 22 January 2026. The latest transaction was filed on 22 January 2026 (Purchase). Regulator: FSMA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration